Lung cancer is a complex disease that often manifests at the point when treatment is not
effective. Introduction of blood-based complementary diagnostics using molecular markers …

Background Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancers.
This study aimed to discover the potential miRNA biomarkers for early detection of NSCLC …

Background: Micro (mi) RNAs, potent gene expression regulators associated with
tumorigenesis, are stable, abundant circulating molecules, and detectable in plasma. Thus …

Background Altered expression of miRNA expression contributes to human carcinogenesis.
This study was designed to detect aberrant miRNA expressions as a potential biomarker for …

Non‑small cell lung cancer (NSCLC) is the leading cause of cancer‑related mortality in the
world. Late diagnosis is one of the most significant reasons for the high mortality rate of lung …

Background and Aim: Lung Cancer (LC) is a major cancer killer worldwide, and 5-yr survival
is extremely poor (≤ 15%), accentuating the need for more effective diagnostic and …

Current clinical diagnostic methods lack the specificity in detecting lung cancer patients. The
issue is particularly critical for stage I and II patients. Considerable evidence showed …

Aim: Circulation miRNAs have become increasingly appreciated in the diagnosis and
prognosis of lung cancer. This study aims to identify and evaluate plasma miRNA-30a-5p as …

Background Lung cancer is one of the most malignant cancers threatening human health.
The miR-17-92 gene cluster is a highly conserved oncogene cluster encoding 6 miRNAs …

Background Many studies have shown that differentially expressed miRs in body fluids can
serve as biomarkers in non-invasive detection of the cancers. However, the clinical …